Open access
Aug 2026
Tumor Mutational Landscape and Its Correlation With Histopathological Characteristics in Breast Cancer
The routine implementation of comprehensive genomic profiling in metastatic HER2-negative breast cancer, especially in metastatic HER2-negative breast cancer, is supported to guide precision oncology strategies and enable enrollment in biomarker-driven clinical trials.
E. Papadopoulou, M. Stathoulopoulou, M. Matiatou et al.
· Cancer Genomics & Proteomics · 0 citations